3 Monster Stocks to Buy Right Now With Dividend Yields of 5% or More

The article highlights three high-yield income stocks: Enterprise Products Partners at 6.1%, Pfizer at 7.2%, and Verizon at 6.2%, all with long dividend growth streaks. It argues that Enterprise has strong balance-sheet support and $5.3 billion of projects under construction, Pfizer has a 96-program pipeline despite patent-cliff risks, and Verizon is generating rising free cash flow with at least $21.5 billion expected in 2026. Overall, this is a bullish income-investing piece rather than a catalyst-driven market event.

Analysis

The common setup here is not just yield; it is balance-sheet durability versus the market’s bias to treat all high payouts as fragile. EPD screens best because midstream cash flows are increasingly tied to volume growth from NGL export, gas processing, and data-center-linked power demand, which gives it a cleaner path to sustaining distributions than a generic income basket. Relative to peers, the market is still underpaying for the combination of investment-grade financing access and visible project backlog, so the risk/reward favors names with self-funded growth rather than pure yield support.

PFE is the more interesting contrarian situation: the market is pricing the patent cliff as if the cash drag is immediate and linear, but that tends to ignore pipeline optionality and capital allocation flexibility. The key second-order issue is whether management can bridge the 2026-2028 earnings gap without overpaying for external growth; if they can, the multiple can re-rate before the obesity asset or any late-stage oncology readout contributes meaningfully. The stock is likely to remain range-bound near term, but any sign of pipeline de-risking can produce a sharp rerating because expectations are already depressed.

VZ is less of a “bond proxy” and more of a self-help story with duration: improving cash conversion and broadband/fiber mix can support the dividend while the market waits for 6G optionality. The bigger competitive implication is that higher fiber density can improve retention and pricing power in the consumer bundle, which matters more than headline subscriber adds over the next 12-24 months. The main risk is that capex intensity rises again just as investors start to believe in the turnaround, compressing FCF yield and capping upside.

The consensus misses that the best risk-adjusted income trade may be owning the names where yield is paired with internal reinvestment, not the absolute highest yield. In a stable-rate or gently falling-rate environment, these names can outperform simply because their distributions look sustainable while duration-sensitive income substitutes get repriced. If rates back up materially, all three get hit, but PFE is most vulnerable on sentiment and VZ on valuation, while EPD should be the most resilient on fundamentals.

Key Decisions for Investors

• Long EPD on pullbacks over the next 2-6 weeks; target a 10-15% total return profile including distributions, with downside limited by project visibility and stronger balance sheet than midstream peers.
• Pair trade: long EPD / short a lower-quality high-yield infrastructure or telecom proxy over 3-6 months; thesis is quality dividend compounding versus yield trap compression.
• Buy PFE only as a patient 6-12 month turnaround optionality trade; size smaller than EPD/VZ because near-term catalyst latency is high, but the stock offers attractive upside if pipeline confidence improves.
• Sell cash-secured puts on VZ 3-6 months out at strikes where forward yield exceeds ~7%; this monetizes the market’s skepticism while leaving room for FCF-driven stabilization.
• Avoid chasing the highest headline yield in the sector basket; prefer a barbell of EPD and selective PFE, since VZ’s upside is more capped unless the turnaround accelerates faster than consensus expects.